The London Cancer Hub

The London Cancer Hub is a collaboration between The Institute of Cancer Research, London, and the London Borough of Sutton, with the support of The Royal Marsden NHS Foundation Trust and the Greater London Authority.

Based in Sutton, south London, The London Cancer Hub will potentially create more than 13,000 jobs and will enhance the discovery of new cancer treatments.

Recent discoveries at this centre

breast cancer cell
Major trial shows prolonged benefit of olaparib in early-stage inherited breast cancer

12/12/24

One year of treatment with the targeted drug olaparib improves long-term survival in women with high-risk, early-stage breast cancer with mutations in BRCA1 or BRCA2 genes, new results from a major clinical trial show.
See full story
Breast cancer cell spheroid blue and purple
New understanding of aggressive form of breast cancer paves the way for tests and treatments

10/12/24

Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to treatment, and when it will return.
See full story
Breast cancer cell
Scientific achievements of 2024

02/12/24

We've selected a range of discoveries from 2023/24 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
See full story
Johann de Bono and Mateus Crespo Prostate cancer cells 547x410
Scientists can predict how long prostate cancer patients will respond to olaparib

21/11/24

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP inhibitor drug, olaparib, according to new research published in the journal Cancer Cell.
See full story

Royal Marsden centres

With The Royal Marsden we work across several centres to take the results of our research rapidly into the clinic to develop better treatments for cancer patients.

Other strategic partner centres

We’ve developed collaborations with several major partners to share expertise and resources to deliver world-class research that can rapidly benefit patients.